The Construction of Market Credit Supervision System for Pharmaceutical Enterprises in Liaoning Province

Abstract

Objective To study the construction of market credit supervision systems for pharmaceutical enterprises in Liaoning Province and to provide suggestions for improving the integrity awareness and production activities. Methods Based on the market credit supervision experience of National Medical Products Administration and some other provinces, the construction of supervision laws and regulations system for pharmaceutical enterprises in Liaoning Province was investigated from the perspectives of daily supervision and inspection, joint punishment of illegal acts, sampling results, information communication and publicity. Results and Conclusion In recent years, Liaoning Provincial Party Committee and the People’s Government of Liaoning Province has attached great importance to the construction of social credit system by issuing a series of local regulations and local government rules. However, the laws and regulations on the market credit supervision of pharmaceutical enterprises are not perfect, and there is a lack of legal documents such as the credit rating method. Besides, some regulatory documents are slightly outdated and they should be revised in time according to the development of the pharmaceutical industry. The Food and Drug Administration of Liaoning Province should promulgate some relevant laws and regulations on the market credit supervision of pharmaceutical enterprises as soon as possible. Firstly, Liaoning Drug Administration should formulate the “Measures for the Administration of Drug Safety Credit of Pharmaceutical Enterprises”, including the establishment of credit information management system, which can clarify the main responsibility of pharmaceutical enterprises and key personnel, and standardize drug advertising and advertising endorsement. Secondly, Liaoning Drug Administration should introduce the “Credit Rating Methods for Pharmaceutical Enterprises”, and divide the credit rating of pharmaceutical enterprises into four grades from high to low. Besides, differentiated credit supervision measures must be implemented. Finally, the Pharmaceutical Industry Association of Liaoning Province should issue the industry norms that regard drug quality as life so as to improve the integrity awareness of pharmaceutical enterprises and promote the production activities.

Keywords

Liaoning Province / drug safety / pharmaceutical enterprise / credit regulatory system

References

[1] Cao Xing, Tian Lijuan. Analysis on the construction of credit supervision mechanism of pharmaceutical production and operation enterprises[J]. Journal of Shenyang Pharmaceutical University, 2019, 36 (5): 446-449.

[2] National Medical Products Administration. Drug Administration Law of the People’s Republic of China[EB/OL]. (2019-08-27)[2022-06-15]. https://www.nmpa.gov.cn/xxgk/fgwj/flxzhfg/20190827083801685.html.

[3] Writing Help. On the implementation of the drug safety credit system by the Food and Drug Administration of Liaoning Province[EB/OL]. (2010-04-29)[2022-06-15]. https://www.xiebang.com/a13/201905156/2d38ed1E6be37215.html.

[4] Liaoning Drug Administration. Strengthening the normalization of law popularization and promoting the implementation of corporate main responsibility[EB/OL]. (2021-04-25)[2022-06-15]. https://ypjg.ln.gov.cn/ypjg/qt/jgyw/FB9D942F9AFA4114A8057BD09BDF3D38/index.shtml.

[5] National Medical Products Administration. Notice on Printing and Distributing the Interim Provisions on Drug Safety Credit Classification Management[EB/OL]. (2004-09-13)[2022-06-15]. https://www.nmpa.gov.cn/xxgk/fgwj/ gzwj/gzwjyp/20040913010101393.html.

[6] National Medical Products Administration. Management Regulations (Trial)[EB/OL]. (2012-08-15)[2022-06-15]. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20120815112201353.html.

[7] National Medical Products Administration. Guiding Opinions on Promoting the Construction of Food and Drug Safety Credit System[EB/OL]. (2015-11-19) [2022-06-15]. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjzh/20151119120001613.html.

[8] Shanghai Urban Regulations. Shanghai Social Credit Regulations[EB/OL]. (2017-06-23)[2022-06-15]. https://law.sfj.sh.gov.cn/#/detail?id=c3d18cd20e2c22a4bc8f23f581fc9e99.

[9] Shanghai Municipal People’s Government. Management Measures of Shanghai Public Credit Information Collection and Use[EB/OL]. (2015-12-30)[2022-06- 15]. https://www.shanghai.gov.cn/xxzfgzwj/20210608/f19710f2d3224a618ad3d55bd159daeb.html.

[10] Zhejiang Drug Administration. Management Measures for the List of Serious Dishonest in Food and Drug Safety in Zhejiang Province[EB/OL]. (2016-12-22) [2022-06-15]. http://mpa.zj.gov.cn/art/2016/12/22/art_1229136205_629751.html.

[11] Zhejiang Drug Administration. Measures for the Administration of Drug Safety Credit of Pharmaceutical Manufacturing Enterprises in Zhejiang Province (Trial)[EB/OL]. (2021-11-11)[2022-06-15]. http://mpa.zj.gov.cn/art/2021/11/11/art_1229136205_2373172.html.

[12] Shaanxi Provincial People’s Government. Implementation Opinions on Accelerating the Construction of the Social Credit System in Shaanxi Province[EB/OL]. (2008-06-26)[2022-06-15]. http://www.shaanxi.gov.cn/zfxxgk/zfgb/2007/d18q_4259/200806/t20080626_1637952.html.

[13] Shaanxi Provincial People’s Government. Measures for the Supervision and Administration of Enterprise Credit in Shaanxi Province[EB/OL]. (2017-04-18)[2022-06- 15]. http://www.shaanxi.gov.cn/zfxxgk/fdzdgknr/zcwj/nszfgz/202208/t20220804_2233170.html.

[14] Shaanxi Drug Administration. The Information Sharing and Joint Disciplinary Measures (Trial) of the Blacklist Information Sharing and Joint Disciplinary Measures (Trial) of Drug Safety in Shaanxi Province[EB/OL]. (2020-11-18)[2022-06-15]. https://mpa.shaanxi.gov.cn/info/1006/41059.htm.

[15] Tianjin People’s Congress. Tianjin Social Credit Regulations[EB/OL]. (2020-12-06)[2022-06-15]. https://www.tjrd.gov.cn/flfg/system/2020/12/07/030018650.shtml.

[16] Tianjin Municipal Market Supervision and Management Committee. Interim Measures for Credit Evaluation and Classification Supervision of Pharmaceutical Enterprises in Tianjin[EB/OL]. (2021-01-29)[2022-06-16]. https://scjg.tj.gov.cn/tjsscjdglwyh_52651/tjyj/ZWGK149660/ZFGZ149668/gfxwjyjjnew/202301/t20230123_6087089.html.

[17] Writing Help. On Printing and Distributing Liaoning Social Credit System Development Plan[EB/OL]. (2019-05-13)[2022-06-16]. https://www.xiexiebang.com/a5/2019051318/1c4f805d5a70df2c.html.

[18] National Laws and Regulations Database. Liaoning Social Credit Regulations[EB/OL]. (2021-11-26)[2022- 06-16]. https://flk.npc.gov.cn/detail2.html?ZmY4MDgxODE3ZTAwOTA2YjAxN2UwOTgxZmNmMDIwMzk.

[19] Liaoning Provincial People’s Government. Notice on Printing and Issuing the Plan for the Construction of Social Credit System in Liaoning Province during the 14th Five-Year Plan[EB/OL]. (2022-01-03)[2022-06-16]. http://www.ln.gov.cn/zwgkx/zfwj/szfbgtwj/zfwj2011_153687/202201/t20220120_4494382.html.

[20] National Laws and Regulations Database. Liaoning Province Punishment of Serious Breach of Trust Provisions[EB/OL]. (2021-05-27)[2022-06-16]. https://flk.npc.gov.cn/detail2.html?ZmY4MDgxODE 3YjE0OWQ2MjAxN2IyZTAwZWI1YzJjMmM.

[21] Liaoning Provincial People’s Government. Decision of the People’s Government of Liaoning Province on Strengthening the Construction of Honest Government[EB/OL]. (2019-12-24)[2022-06-16]. http://www.ln.gov.cn/zwgkx/zfxxgk1/zc/ZFGZ_158327/gfxwj/202212/t20221229_4723865.html.

[22] Wu Weizhong, Shen Zhaoxiang. How to speed up the pace of food and drug enterprises credit system construction[J]. Modern Food, 2015 (20): 7-10+29.

[23] Sun Qiang, He Zhaoyun, Wang Xinjian. Supervision practice and thinking on ensuring the quality and safety of drug production in Shandong Province[J]. China Food and Drug administration, 2022 (11): 74-79.